MaxPlanck-Innovation

Max Planck #Innovation is responsible for the #technologytransfer of the Max Planck Institutes. We market the inventions of thousands of scientists to industry.

[MaxPlanck-Innovation @MP_Innovation]

Start-up @meshcapade, a spin-off from the MaxPlanck Institute for Intelligent Systems, is being acquired by @EpicGames. Epic will establish a presence in Tübingen, strengthening the region’s AI and 3D technology ecosystem. https://t.co/8mWkmJJm2r #AI #TechTransfer #CyberValley

[MaxPlanck-Innovation @MP_Innovation]

🚀 How do Europe’s public research organisations turn breakthrough science into real-world impact?
Join the @EPOorg on 22 October for their online event and register now under https://t.co/4H1LAnj4C2

[MaxPlanck-Innovation @MP_Innovation]

🚀 New video is live: Essentials for your Perfect Start-up Pitch. We’ll show you how to deliver a compelling pitch that stands out and wins people over.
Watch Video Nr. 6 now:
👉 https://t.co/hc9VOk2SeZ
#Innovation #Startups #TechTransfer #GoBioInitial

[MaxPlanck-Innovation @MP_Innovation]

🎶 New Hope for Stroke Recovery Through Music & Movement 🎶Official release of the JYMMiN Face Active App — a groundbreaking therapeutic tool to help people with facial paralysis regain muscle control and expressiveness after strokes: https://t.co/oNJL4VIuBx

[MaxPlanck-Innovation @MP_Innovation]

🌟 More Hope for Pregnancy: Ovo Labs Raises £4 Million in Seed Funding!
We are thrilled to announce major leap forward for reproductive health 🚀
@OvoLabsGmbH , a spin-off from the @mpi_nat , develops drugs to improve success of fertility treatments: https://t.co/sENOuOszM4 🧬💖

[MaxPlanck-Innovation @MP_Innovation]

🚀 Ready for the next generation of life science innovation?
We’re excited to be showcasing our latest cutting-edge technologies at @BioVaria 2025.
👉 Find out more about the presented technologies: https://t.co/XgN34O44aI
🔗
#BioVaria2025 #LifeSciences #Innovation #TechTransfer

[MaxPlanck-Innovation @MP_Innovation]

🚀 Big news in #biotech & #nutrition!

eversyn, a spin-off from the Max Planck Institute for Dynamics of Complex Technical Systems, has secured €1.6M in seed funding to scale its cell-free enzymatic technology. This innovation enables the efficient production of complex glycans—a true breakthrough for biopharma and nutrition!

Max Planck Innovation is proud to have supported this journey from patenting to funding. Huge thanks to bmp ventures, the Max Planck Society, MPF Start-Up Accelerator, and everyone driving deep-tech innovation forward!

🔗 Read the full announcement here: https://t.co/7UQWqUDMNZ

#Innovation #TechTransfer #Biopharma #Startups #MaxPlanckInnovation #eversyn #SeedFunding
#Glycans #FutureOfFood

[MaxPlanck-Innovation @MP_Innovation]

🎉 Promoting Mental Health with the Smartwatch App Actiself 🎉

We are excited to announce the launch of Actiself, a revolutionary app that combines scientific expertise from the Max Planck Institute of Psychiatry @mpi_psychiatry with innovative wearable technology to improve mental health.

Developed as part of a Max Planck research @maxplanckpress project and now brought to market by the spin-off company Biomentric through a licensing agreement facilitated by Max Planck Innovation, Actiself is a shining example of how groundbreaking science can drive impactful innovations.

💡 What Makes Actiself Special?
Actiself supports individuals experiencing stress-related symptoms like sleep problems, fatigue, or constant overthinking. It helps patients by offering:
✔ Personal insights into their behavioral profiles
✔ A six-week program to promote an active and balanced lifestyle
✔ Evidence-based interventions rooted in the latest psychiatric research

This app bridges the gap between cutting-edge research and accessible care, making life-changing tools available to people who need them most.

A huge thank you to the Max Planck Institute of Psychiatry, Biomentric and @BornholdtLee for their collaboration on this impactful project. Together, we are helping patients live healthier, more balanced lives.

🌍 Let’s shape the future of mental health together!
Visit https://t.co/Efva5BYI5a to download the app. Also see our press release on the launch under
https://t.co/wHsfP8J74T

#MentalHealthMatters #ScientificInnovation #MaxPlanck #Actiself #science #innovation #startup

[MaxPlanck-Innovation @MP_Innovation]

🚀 KHAN-II Secures First Closing at €51 Million – Targeting €100 Million for Groundbreaking Drug Discovery! 💡💰

We are excited to announce the first closing of our KHAN Technology Transfer Fund II (KHAN-II)! With the strong commitment of partners such as the European Investment Fund @EIF_EU , Akros Pharma Inc. @JTI_global , the Max Planck Foundation, Thyssen’sche Handelsgesellschaft, and KHAN-II Vermögensverwaltung, we have already secured €51 million to invest in early-stage drug discovery – but this is just the beginning!

🎯 Our goal: €100 million to advance cutting-edge drug discovery projects from top-tier research into clinical applications. A co-investment agreement with the Max Planck Society @maxplanckpress , is adding €18 millionto support groundbreaking projects.

📍 Why KHAN-II?
✅ Focus on first-in-class therapies addressing high unmet medical needs
✅ Strong partnership with leading academic institutions like the Max Planck Institutes
✅ Project execution at Lead Discovery Center GmbH @LDC_GmbH, Dortmund, a premier drug discovery incubator
✅ A unique opportunity for investors to be part of a high-impact translational ecosystem

💬 Bram Wijlands, Managing Director of Max Planck Innovation, emphasizes:
"KHAN-II builds on the strong foundation of KHAN-I and further strengthens our commitment to early-stage drug discovery. This new fund will drive cutting-edge projects, particularly from the world-class research of the Max Planck Institutes, to bring transformative innovations closer to clinical application."

📢 We are inviting additional investors to join this unique opportunity!

Let’s shape the future of drug discovery together.
🔗 More info: https://t.co/HXhNIEsWQx

#Fundraising #DrugDiscovery #KHANII #EarlyStageInvesting #MaxPlanckSociety #LDC #Research #Biotech #Investment #HealthcareInnovation

[MaxPlanck-Innovation @MP_Innovation]

🚀 A New Chapter of Innovation at Max Planck Innovation! 🚀

We’re excited to announce that, starting in January 2025, Christoph Hüls will join Bram Wijlands as the new dual leadership team at Max Planck Innovation GmbH! Together, they’ll drive forward our mission to turn groundbreaking research conducted at the Max Planck Society into impactful real-world solutions.

As we look to the future, we also reflect with gratitude. After over 30 years of service, nearly 20 years as Managing Director, Jörn Erselius is retiring. His visionary leadership paved the way for major successes like RNA interference technology and the cancer drug Sutent — milestones that have left a lasting legacy on science, society, and the Max Planck Society.

With Hüls’s deep expertise in startups, patents, and licensing, combined with Wijlands’s experience in spin-offs, we are poised to unlock new opportunities for innovation and impact.

Join us in welcoming Christoph Hüls and thanking Jörn Erselius for his extraordinary contributions! 🙌

More under: https://t.co/8vkwHkBNON

#Leadership #Innovation #MaxPlanck #TechnologyTransfer #ThankYouJörn #WelcomeChristoph

[MaxPlanck-Innovation @MP_Innovation]

🌟 Celebrating Innovation and Collaboration! 🌟
We are proud to highlight the incredible efforts of @ArtemiflowUSA , a spin-off from the Max Planck Institute of Colloids and Interfaces! Together with Manus, ArtemiFlow is securing the future of critical medicine production.
💡 What happened?
ArtemiFlow has secured $5.8 million as part of a partnership with Manus to produce essential medicines, including malaria drugs, more efficiently and sustainably.
🔬 Using ArtemiFlow´s innovative flow chemistry based on research from the research team around @peterseeberger, this partnership establishes an environmentally friendly and cost-effective manufacturing process that could revolutionize global medicine supply chains.
🤝 Collaboration with Manus:
Manus, the world leader in bioalternatives, recently received $32.4 million in government funding and brings these resources to the partnership. Together, they are creating a stable and sustainable infrastructure for medicine production in the U.S.
🎉 This is a fantastic example of how outstanding basic research from Max Planck Institutessignificantly benefits society!
📸 In the image: Artemisia annua (sweet wormwood), the plant source for the malaria drug artemisinin.
Get the full story: https://t.co/yMzGbS7BHT
#Innovation #Medicine #MaxPlanck #ArtemiFlow #Manus #Bioeconomy #Collaboration

[MaxPlanck-Innovation @MP_Innovation]

🚀 New Video: Building the Dream Team for Your Start-up Success! 👩‍💻👨‍💼

Episode 5 of our video series now online! Behind every successful start-up is a powerhouse team of visionaries, problem-solvers, and doers. 💡💪 Whether you’re in the early stages of your journey or scaling up, the people you bring onboard can make all the difference.

🔍 In this video, we’ll cover: ✨ The essential roles every start-up needs at every stage. ✨ How to identify and attract top talent. ✨ Strategies for building a dynamic and cohesive team ready to tackle any challenge.

💼 Whether you’re an entrepreneur or dreaming of building something incredible, this is your blueprint for assembling the ultimate start-up team. Let’s build success together! 🛠️

🎥 Check out the full video now and start shaping your future: https://t.co/Hp3rIPe5Ho

#StartupSuccess #DreamTeam #Entrepreneurship #TeamBuilding #StartUpJourney #GoBioInitial

[MaxPlanck-Innovation @MP_Innovation]

📈 Build Your Business Plan – Join the Final GO-Bio Initial Webinar on December 11, 2024! 📈

A strong business model and plan are crucial for turning research into a viable business. The webinar will cover:

- Choosing the best business model for your idea
- Elements of a solid business plan
- Steps to attract funding and stakeholders

🗓 Date: December 11, 2024
🕓 Time: 4:00 - 5:00 PM (CET)
📍 Don’t miss out – register here: https://t.co/53WTFR127C

Let’s build your roadmap to entrepreneurial success!
#Webinar #Startups #Innovation #Patents #GoBioInitial #TechTransfer #BusinessPlan #Funding

[MaxPlanck-Innovation @MP_Innovation]

🚀 Breaking New Ground in Science and Innovation! 🌟
The company JEOL-IDES @JEOL_Japan has licensed groundbreaking electron beam technology, revolutionizing ultrafast transmission electron microscopy (UTEM) from @maxplanckpress, @mpi_nat and @uniGoettingen

🔬✨ This cutting-edge tech integrates laser-driven electron emitters, enabling unparalleled precision and speed in observing ultrafast processes at the nanoscale.

📸 Imagine the possibilities for materials science, biology, and nanotechnology as scientists unlock the secrets of light-matter interactions at the atomic scale!

🔗 Collaboration between academia and industry makes this leap possible, ensuring that innovations are refined for broader applications in both research and industrial settings.

💡 “This is one of those rare collaborations where there’s a natural fit at every level. If you ever wanted to play with ultrafast light-matter interactions at the atomic scale, now’s your chance,” says Dr. Bryan Reed, JEOL-IDES.

🌐 Learn more about how this partnership is driving innovation and delivering benefits across scientific and technological fields: https://t.co/mhWrptoZ4H

#Innovation #Science #Nanotechnology #ElectronMicroscopy #Collaboration #JEOLIDES #MaxPlanckSociety #TechnologyTransfer

[MaxPlanck-Innovation @MP_Innovation]

Pitch Deck Preparation
🎤 Make an Impact with Your Pitch – Join Us for the Third GO-Bio Initial Webinar on December 4, 2024! 🎤
Knowing how to effectively communicate your research to non-experts is essential. In the “Pitch Deck” session we will share insights on:
- Building a compelling pitch deck
- Tailoring complex scientific concepts for investors
- Common do’s and don’ts when presenting your venture

🗓 Date: December 4, 2024
🕓 Time: 4:00 - 5:00 PM (CET)
📍 Register now to reserve your spot: https://t.co/53WTFR127C

Perfect your pitch and make a lasting impression!
#Webinar #Startups #Innovation #Patents #GoBioInitial #TechTransfer #PitchDeck #Investors

[MaxPlanck-Innovation @MP_Innovation]

Intellectual Property and FTO
🛡️ Protect Your Ideas – Join Us for the Next GO-Bio Initial Webinar on November 28, 2024! 🛡️

Intellectual property (IP) protection is crucial for any innovative venture. Join us in the “Intellectual Property and FTO” session to explore:
- Key steps in securing your IP
- Understanding the concept of “freedom to operate” (FTO)
- Common pitfalls and how to avoid them when managing IP in early-stage ventures

🗓 Date: November 28, 2024
🕓 Time: 4:00 - 5:00 PM (CET)
📍 Register here to save your spot: https://t.co/53WTFR127C

Make sure your innovative ideas are safeguarded as you move toward commercialization!

#Webinar #Startups #Innovation #Patents #GoBioInitial #TechTransfer #IntellectualProperty #FTO

[MaxPlanck-Innovation @MP_Innovation]

Principles of Tech-Transfer
🚀 Join Us for the First of 4 GO-Bio Initial Webinars on November 21, 2024! 🚀

Are you ready to take the first step in translating your research into a business? Start with the “Principles of Tech-Transfer” session, Sebastian, Senior Start-up & Portfolio Manager at Max Planck Innovation, will guide you through:
The fundamentals of technology transfer
Identifying potential markets for your research
Initial steps for transitioning from research to business

🗓 Date: November 21, 2024
🕓 Time: 4:00 - 5:00 PM (CET)
📍 Register now to secure your spot: https://t.co/53WTFR127C

Don't miss out on this essential first session to kickstart your entrepreneurial journey!

#Webinar #Startups #Innovation #Patents #GoBioInitial #TechTransfer

[MaxPlanck-Innovation @MP_Innovation]

Good Morning! 🌞
We’re thrilled to have been part of BIO-Europe in Stockholm this year! A big thank you to BIO-Europe for hosting such an incredible event packed with valuable networking, partnership opportunities, and insights into the future of life sciences.
Our team had a fantastic time connecting with leaders from biotech, pharma, and industry, discussing new licensing opportunities based on innovative Max Planck technology. From inspiring one-to-one meetings to eye-opening discussions on the Swedish approach to biotech innovation, we’re leaving BIO-Europe with fresh perspectives and a renewed drive to foster collaborations that push boundaries in life sciences.
Here’s to the partnerships and connections that will shape tomorrow’s breakthroughs. Thanks again to everyone who made this experience unforgettable! 🚀
#BIOEurope #MaxPlanckInnovation #Networking #Partnerships #LifeSciences #Innovation #Patents #Licensing

[MaxPlanck-Innovation @MP_Innovation]

🚨 New Hope for Vision Restoration! 🚨

We’re proud to announce that Max Planck Innovation has licensed the groundbreaking CatCh technology from the @MPIbp to @NSTherapeutics, offering new hope for patients suffering from genetic eye diseases like retinitis pigmentosa and Stargardt disease. 👁️💡

By integrating CatCh into their MCO-010 gene therapy platform, Nanoscope is paving the way for restoring vision in those with severe visual impairments.

With @US_FDA fast-track designation and encouraging clinical trial results, this transformative therapy is one step closer to changing lives. 💪💊

Thrilled to see this partnership help bring scientific breakthroughs to patients in need.

🔗 https://t.co/3l8eJ4rtYg

#GeneTherapy #VisionRestoration #Optogenetics #NanoscopeTherapeutics #BiotechInnovation